Mary Réquena

650 total citations
18 papers, 504 citations indexed

About

Mary Réquena is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Mary Réquena has authored 18 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Virology, 12 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Mary Réquena's work include HIV Research and Treatment (17 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (3 papers). Mary Réquena is often cited by papers focused on HIV Research and Treatment (17 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (3 papers). Mary Réquena collaborates with scholars based in France, Australia and United States. Mary Réquena's co-authors include Laurent Bélec, Héla Saïdi, Nadine Nasreddine, Jacques Izopet, Pierre Delobel, Michelle Cazabat, Giuliana Magri, Karl Barange, Hicham Bouhlal and Martine Dubois and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Gut.

In The Last Decade

Mary Réquena

16 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Réquena France 12 300 228 194 105 66 18 504
Meghan Rothenberger United States 6 455 1.5× 135 0.6× 350 1.8× 100 1.0× 56 0.8× 14 644
Piera Pierotti Italy 10 272 0.9× 104 0.5× 226 1.2× 74 0.7× 36 0.5× 21 402
Rúbia Marília de Medeiros Brazil 15 309 1.0× 79 0.3× 236 1.2× 151 1.4× 49 0.7× 25 448
Marie‐France Huguet France 13 186 0.6× 238 1.0× 106 0.5× 139 1.3× 35 0.5× 24 449
Levelle D. Harris United States 8 560 1.9× 452 2.0× 292 1.5× 243 2.3× 115 1.7× 9 838
M. B. Vasudevachari United States 12 693 2.3× 140 0.6× 550 2.8× 196 1.9× 126 1.9× 21 861
Bruno De Rienzo Italy 12 274 0.9× 211 0.9× 194 1.0× 219 2.1× 93 1.4× 26 567
Nicole L. Yates United States 12 437 1.5× 365 1.6× 155 0.8× 89 0.8× 106 1.6× 24 588
M. Juliana McElrath United States 4 263 0.9× 197 0.9× 113 0.6× 106 1.0× 71 1.1× 5 344
Christopher A. Todd United States 9 369 1.2× 193 0.8× 212 1.1× 140 1.3× 120 1.8× 12 580

Countries citing papers authored by Mary Réquena

Since Specialization
Citations

This map shows the geographic impact of Mary Réquena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Réquena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Réquena more than expected).

Fields of papers citing papers by Mary Réquena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Réquena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Réquena. The network helps show where Mary Réquena may publish in the future.

Co-authorship network of co-authors of Mary Réquena

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Réquena. A scholar is included among the top collaborators of Mary Réquena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Réquena. Mary Réquena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Collercandy, Nived, Manon Nayrac, Mary Réquena, et al.. (2025). Cytotoxic CX3CR1+ Vδ1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapy. PLoS Pathogens. 21(9). e1013489–e1013489.
2.
Réquena, Mary, Manon Nayrac, Nived Collercandy, et al.. (2024). Compartmentalized Human Immunodeficiency Virus Type 1 Reservoir in Intestinal Monocytes/Macrophages on Antiretroviral Therapy. The Journal of Infectious Diseases. 231(3). 611–621. 2 indexed citations
3.
Nayrac, Manon, Nived Collercandy, Mary Réquena, et al.. (2023). Intact proviruses are enriched in the colon and associated with PD-1+TIGIT− mucosal CD4+ T cells of people with HIV-1 on antiretroviral therapy. EBioMedicine. 100. 104954–104954. 7 indexed citations
4.
Nayrac, Manon, Mary Réquena, Michelle Cazabat, et al.. (2020). Th22 cells are efficiently recruited in the gut by CCL28 as an alternative to CCL20 but do not compensate for the loss of Th17 cells in treated HIV-1-infected individuals. Mucosal Immunology. 14(1). 219–228. 8 indexed citations
5.
Réquena, Mary, Manon Nayrac, Maud Mavigner, et al.. (2019). Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection. The Journal of Infectious Diseases. 220(5). 830–840. 11 indexed citations
6.
Marion, Olivier, Sébastien Lhomme, Manon Nayrac, et al.. (2019). Hepatitis E virus replication in human intestinal cells. Gut. 69(5). 901–910. 64 indexed citations
7.
Raymond, Stéphanie, Florence Nicot, Romain Carcenac, et al.. (2016). No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV-infected patients on suppressive maraviroc therapy. AIDS. 30(6). 965–968.
8.
Réquena, Mary, Maud Mavigner, Michelle Cazabat, et al.. (2016). CCR6− regulatory T cells blunt the restoration of gut Th17 cells along the CCR6–CCL20 axis in treated HIV-1-infected individuals. Mucosal Immunology. 9(5). 1137–1150. 32 indexed citations
9.
Delobel, Pierre, Michelle Cazabat, Adrien Saliou, et al.. (2013). Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence. Journal of Antimicrobial Chemotherapy. 68(11). 2506–2514. 9 indexed citations
10.
Chapuy‐Regaud, Sabine, Caroline Subra, Mary Réquena, et al.. (2013). Progesterone and a phospholipase inhibitor increase the endosomal bis(monoacylglycero)phosphate content and block HIV viral particle intercellular transmission. Biochimie. 95(9). 1677–1688. 22 indexed citations
11.
Mavigner, Maud, Michelle Cazabat, Martine Dubois, et al.. (2011). Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. Journal of Clinical Investigation. 122(1). 62–69. 127 indexed citations
12.
Jenabian, Mohammad-Ali, Hicham Bouhlal, Hakim Hocini, et al.. (2008). Infection of Macrophages and Dendritic Cells with Primary R5-Tropic Human Immunodeficiency Virus Type 1 Inhibited by Natural Polyreactive Anti-CCR5 Antibodies Purified from Cervicovaginal Secretions. Clinical and Vaccine Immunology. 15(5). 872–884. 15 indexed citations
13.
Bouhlal, Hicham, Nicolas Chomont, Mary Réquena, et al.. (2007). Opsonization of HIV with Complement Enhances Infection of Dendritic Cells and Viral Transfer to CD4 T Cells in a CR3 and DC-SIGN-Dependent Manner. The Journal of Immunology. 178(2). 1086–1095. 49 indexed citations
14.
15.
16.
Saïdi, Héla, Giuliana Magri, Nadine Nasreddine, Mary Réquena, & Laurent Bélec. (2006). R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: Implication for mechanisms of sexual transmission. Virology. 358(1). 55–68. 59 indexed citations
17.
Saïdi, Héla, Giuliana Magri, Cédric Carbonneil, et al.. (2006). IFN-γ-activated monocytes weakly produce HIV-1 but induce the recruitment of HIV-sensitive T cells and enhance the viral production by these recruited T cells. Journal of Leukocyte Biology. 81(3). 642–653. 12 indexed citations
18.
Bouhlal, Hicham, Mary Réquena, Srini V. Kaveri, et al.. (2005). Natural Antibodies to CCR5 from Breast Milk Block Infection of Macrophages and Dendritic Cells with Primary R5-Tropic HIV-1. The Journal of Immunology. 174(11). 7202–7209. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meghan Rothenberger Breakdown of academic impact, for papers by Piera Pierotti Breakdown of academic impact, for papers by Rúbia Marília de Medeiros Breakdown of academic impact, for papers by Marie‐France Huguet Breakdown of academic impact, for papers by Levelle D. Harris Breakdown of academic impact, for papers by M. B. Vasudevachari Breakdown of academic impact, for papers by Bruno De Rienzo Breakdown of academic impact, for papers by Nicole L. Yates Breakdown of academic impact, for papers by M. Juliana McElrath Breakdown of academic impact, for papers by Christopher A. Todd
Rankless by CCL
2026